Skip to content

Impact of Surgical Position on Stone-Free Rates in Retrograde Intrarenal Surgery

Does the Positioning in Retrograde Intrarenal Surgery Affect Stone-Free Rates? A Prospective Randomized Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06809582
Acronym
POS-RIRS-RCT
Enrollment
128
Registered
2025-02-05
Start date
2025-01-01
Completion date
2026-06-01
Last updated
2025-08-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stone, Kidney, Stone;Renal, Stones, Kidney

Brief summary

The goal of this clinical trial is to determine whether the surgical position during retrograde intrarenal surgery (RIRS) affects stone-free rates in adults with kidney stones. The main questions it aims to answer are: * Does the modified lithotomy position result in a higher stone-free rate compared to the standard lithotomy position? * Are there differences in complication rates between the two surgical positions? Researchers will compare patients undergoing RIRS in the standard lithotomy position to those in the modified lithotomy position (30-degree Trendelenburg with elevated surgical side) to assess its impact on stone clearance and surgical outcomes. Participants will: * Be randomly assigned to one of two surgical positions * Undergo RIRS with standard surgical procedures * Have follow-up imaging to assess stone clearance after surgery This study aims to improve surgical techniques and patient outcomes in kidney stone treatment.

Interventions

PROCEDUREThe T-Tilt position

The T-Tilt position is a modified lithotomy position used during retrograde intrarenal surgery (RIRS). In this position: The patient is placed in a 30-degree Trendelenburg position, meaning the head is slightly lower than the feet. The surgical side is elevated at a 30-degree angle to improve access to the kidney. This modified positioning is designed to enhance stone clearance, particularly by facilitating the movement of stone fragments away from the lower kidney calyces, where residual stones often remain. Researchers will compare this position to the standard lithotomy position to determine its impact on stone-free rates and surgical outcomes.

Sponsors

Ondokuz Mayıs University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Presence of single or multiple kidney stones, with the largest stone ≤2 cm * Age ≥18 years * Provided written informed consent to participate in the study * Indicated for retrograde intrarenal surgery (RIRS) as a treatment approach

Exclusion criteria

* Severe cardiovascular disease (e.g., heart failure) * Congenital kidney anomalies (e.g., horseshoe kidney, ectopic kidney) * Concurrent ureteral stones * Pregnancy or planning pregnancy * History of previous kidney surgery on the same side * Active urinary tract infection (UTI) * Coagulopathy or use of anticoagulant therapy that cannot be stopped before surgery

Design outcomes

Primary

MeasureTime frameDescription
Stone-Free Rate After Retrograde Intrarenal Surgery6 weeks post-surgeryThe percentage of participants with no residual kidney stones (≤4 mm fragments) on non-contrast computed tomography (CT) at 6 weeks postoperatively.

Secondary

MeasureTime frameDescription
Postoperative Complication RateWithin 30 days post-surgeryhe percentage of participants experiencing any postoperative complications, classified according to the Clavien-Dindo grading system.

Other

MeasureTime frameDescription
Rehospitalization RateWithin 30 days post-surgeryThe percentage of participants requiring hospital readmission due to complications related to the surgical procedure
Total Laser Energy UsedIntraoperativeThe total Holmium:YAG laser energy (Joules) applied during stone fragmentation

Countries

Turkey (Türkiye)

Contacts

Primary ContactMurat Gulsen
mglotr@gmail.com+905062357421

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026